Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation

Summary:

We studied long-term pulmonary function testing (PFT) in a retrospective cohort of 6-month survivors of allogeneic marrow transplant (BMT) between 1980 and 1997. Of 593 patients, 73, 71 and 65% had adequate data to assess for obstruction, restriction and diffusion impairments respectively. Over 5 years, mean declines in 1-s forced expiratory volume/forced vital capacity (FEV1/FVC), total lung capacity (TLC) and diffusion were 4, 7 and 17%, respectively. TLC and diffusion tended to subsequently increase. In all, 6, 12 and 35% of patients met criteria for obstruction, restriction and impaired diffusion, respectively. Obstruction was less common in recent transplants (5 vs 15%, P=0.004), while restriction and diffusion impairment rates remained stable. There was significantly greater mortality with obstruction (HR 2.0 (1.04–3.95)), and a nonstatistically significant higher mortality rate with restriction (HR 1.6 (0.95–2.75)), but not with impaired diffusion (HR=0.99 (0.65–1.50)). cGVHD (OR 16.7 (2.2–129.8)) and busulfan (OR 2.9 (1.01–8.24)) were associated with obstruction. Marrow from nonsibling or mismatched donors (OR 4.9 (2.2–10.7)) was associated with restriction. In summary, after BMT, decreased diffusion capacity is common and benign; obstruction has decreased in frequency, is rare without cGVHD, and is associated with mortality; nonsibling and mismatched donor are risk factors for restriction.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Quabeck K . The lung as a critical organ in marrow transplantation. Bone Marrow Transplant 1994; 14 (Suppl 4): S19–S28.

    Google Scholar 

  2. Breuer R, Lossos IS, Berkman N, Or R . Pulmonary complications of bone marrow transplantation. Resp Med 1993; 87: 571–579.

    Article  CAS  Google Scholar 

  3. Afessa B, Litzow MR, Tefferi A . Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 425–434.

    Article  CAS  Google Scholar 

  4. Crawford SW, Pepe M, Lin D et al. Abnormalities of pulmonary function tests after marrow transplantation predict nonrelapse mortality. Am J Resp Crit Care Med 1995; 152: 690–695.

    Article  CAS  Google Scholar 

  5. Chan CK . Bone marrow transplantation bronchiolitis obliterans. In Epler GR (ed). Diseases of the Bronchioles. Raven Press: New York, 1994, pp 247–257.

    Google Scholar 

  6. Marras TK, Szalai JP, Chan CK et al. Pulmonary function abnormalities after allogeneic marrow transplantation: a systematic review and assessment of an existing predictive instrument. Bone Marrow Transplant 2002; 30: 599–607.

    Article  CAS  Google Scholar 

  7. Estenne M, Maurer J, Boehler A et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297–310.

    Article  Google Scholar 

  8. American Thoracic Society Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique–1995 update. Am J Resp Crit Care Med 1995; 152: 2185–2198.

  9. Steyerberg EW, Eijkemans MJ, Harrell Jr FE, Habbema JD . Prognostic modeling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stati Med 2000; 19: 1059–1079.

    Article  CAS  Google Scholar 

  10. Stiell IG, Greenberg GH, McKnight RD et al. A study to develop clinical decision rules for the use of radiography in acute ankle injuries. Ann Emergency Med 1992; 21: 384–390.

    Article  CAS  Google Scholar 

  11. Harrell FE, Lee KL, Mark DB . Tutorial in biostatistics multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stati Med 1996; 15: 361–387.

    Article  Google Scholar 

  12. Hanley JA, McNeil BJ . A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839–843.

    Article  CAS  Google Scholar 

  13. Payne L, Chan CK, Fyles G et al. Cyclosporine as possible prophylaxis for obstructive airways disease after allogeneic bone marrow transplantation. Chest 1993; 104: 114–118.

    Article  CAS  Google Scholar 

  14. Duncker C, Dohr D, Von Harsdorf S et al. Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome. Bone Marrow Transplant 2000; 25: 1263–1268.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr Smita Pakhale, Ms Jessica Wright and the late Dr Usha Senitharajah for help with data collection and entry, and Dr Robert Hyland and Dr Michael Hutcheon for sharing their content expertise. Dr Marras is a Canadian Institutes of Health Research and Canadian Thoracic Society postdoctoral fellow and University of Toronto, Department of Medicine clinician scientist trainee. Dr Laupacis is a Senior Scientist of the Canadian Institutes of Health Research. The Ontario Thoracic Society supported this project.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T K Marras.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marras, T., Chan, C., Lipton, J. et al. Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation. Bone Marrow Transplant 33, 509–517 (2004). https://doi.org/10.1038/sj.bmt.1704377

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704377

Keywords

This article is cited by

Search

Quick links